Maravai LifeSciences Holdings, Inc.
MRVI
$3.51
$0.072.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 192.28M | 219.68M | 241.70M | 259.03M | 276.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 192.28M | 219.68M | 241.70M | 259.03M | 276.77M |
| Cost of Revenue | 152.17M | 152.99M | 151.94M | 151.15M | 148.82M |
| Gross Profit | 40.11M | 66.69M | 89.76M | 107.88M | 127.95M |
| SG&A Expenses | 154.78M | 158.47M | 160.45M | 161.77M | 154.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 325.13M | 330.49M | 331.47M | 332.14M | 322.98M |
| Operating Income | -132.84M | -110.82M | -89.77M | -73.11M | -46.21M |
| Income Before Tax | -218.47M | -345.46M | -292.19M | -261.91M | 440.78M |
| Income Tax Expenses | -4.23M | -3.82M | -1.97M | -1.86M | 764.32M |
| Earnings from Continuing Operations | -214.24 | -341.64 | -290.22 | -260.05 | -323.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 93.01M | 148.89M | 127.27M | 114.96M | 98.64M |
| Net Income | -121.24M | -192.76M | -162.95M | -145.09M | -224.90M |
| EBIT | -132.84M | -110.82M | -89.77M | -73.11M | -46.21M |
| EBITDA | -81.41M | -60.63M | -40.31M | -24.73M | 608.00K |
| EPS Basic | -0.84 | -1.35 | -1.15 | -1.03 | -1.65 |
| Normalized Basic EPS | -0.02 | 0.46 | 0.40 | 0.39 | 3.55 |
| EPS Diluted | -0.84 | -1.35 | -1.15 | -1.03 | -1.65 |
| Normalized Diluted EPS | -0.02 | 0.46 | 0.40 | 0.39 | 3.55 |
| Average Basic Shares Outstanding | 574.16M | 571.03M | 562.63M | 551.54M | 541.87M |
| Average Diluted Shares Outstanding | 574.16M | 571.03M | 562.63M | 551.54M | 541.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |